Facilitating access to pneumococcal vaccine for people living with HIV: an experience report.
Rev Esc Enferm USP
; 56: e20210563, 2022.
Article
in English, Portuguese
| MEDLINE | ID: covidwho-2197526
ABSTRACT
OBJECTIVE:
The article describes a strategy to facilitate access to pneumococcal conjugate vaccine 13 (PCV-13) for people living with HIV/AIDS (PLHIV) during the COVID-19 pandemic.METHOD:
report on the experience regarding the organization of a care service for PLHIV in the city of São Paulo to facilitate access to PCV-13 in the framework of the 2020 influenza vaccination campaign during the COVID-19 pandemic.RESULTS:
through the integration between a PLHIV care service and an Immunization Center (CRIE in Portuguese), it was possible to offer PCV-13 to PLHIV at the point of care, reducing physical barriers to access to immunization. Thus, of the 1,906 PLHIV who passed through the service during the period March 23-July 31, 2020, 84.4% (1,609) received the influenza vaccine, PCV-13 or both. Of the 1609 vaccinated, 50.6% (814) were eligible and received PCV-13.CONCLUSION:
offering the vaccine at the point of care and orienting PLHIV on the importance of vaccination as a disease prevention strategy, identifying those eligible to receive it, was an important action carried out by the institution together with the nursing team, as a strategy to facilitate access to vaccination.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Acquired Immunodeficiency Syndrome
/
COVID-19
Topics:
Vaccines
Limits:
Humans
/
Infant
Country/Region as subject:
South America
/
Brazil
Language:
English
/
Portuguese
Journal:
Rev Esc Enferm USP
Year:
2022
Document Type:
Article
Affiliation country:
1980-220X-REEUSP-2021-0563en
Similar
MEDLINE
...
LILACS
LIS